13D/13G Filings - Foresite Capital Fund VI, L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
2:25 pm
Sale
2024-09-30 13G enGene Holdings Inc. Common Stock
ENGN
Foresite Capital Fund VI, L.P. 0
0.000%
-2,500,000decrease
(Position Closed)
Filing
History
2024-12-30
3:32 pm
Purchase
2024-12-23 13G RAPT Therapeutics, Inc.
RAPT
Foresite Capital Fund VI, L.P. 12,500,000
9.300%
12,500,000increase
(New Position)
Filing
History
2024-07-05
9:30 pm
Purchase
2024-06-27 13D Alumis Inc. Common Stock
ALMS
Foresite Capital Fund VI, L.P. 15,152,954
29.200%
15,152,954increase
(New Position)
Filing
2024-06-20
9:00 pm
Purchase
2024-06-10 13G CASI Pharmaceuticals, Inc.
CASI
Foresite Capital Fund VI, L.P. 1,309,383
9.800%
1,309,383increase
(New Position)
Filing
History
2024-02-23
1:32 pm
Purchase
2024-02-16 13G enGene Holdings Inc. Common Stock
ENGN
Foresite Capital Fund VI, L.P. 2,500,000
5.800%
2,500,000increase
(New Position)
Filing
History